In rare cases, measles virus (MV) in children leads to fatal neurological complications such as primary measles encephalitis, post-acute measles encephalitis, subacute sclerosing panencephalitis and measles inclusion-body encephalitis. To investigate the pathogenesis of MV-induced encephalitis, rodent brain-adapted MV strains CAM/RB and CAMR40 were generated. These strains acquired mutations to adapt to the rodent brain during 40 passages in rat brain. However, it is still unknown which genes confer the neurovirulence of MV. We previously established a rescue system for recombinant MVs possessing the backbone of wild-type strain HL, an avirulent strain in mice. In the present study, to identify the genes in CAMR40 that elicit neurovirulence, we generated chimeric recombinant MVs based on strain HL. As a result, recombinant wild-type MV in which the haemagglutinin (H) gene was substituted with that of CAMR40 caused a non-lethal mild disease in mice, while additional substitution of the HL phosphoprotein (P) gene with that of strain CAMR40 caused lethal severe neurological signs comparable to those of CAMR40. These results clearly indicated that, in addition to the H gene, the P gene is required for the neurovirulence of MV CAMR40.
INTRODUCTION
Measles virus (MV) is the causative agent of acute measles, which in humans causes a respiratory disease with fever followed by immunosuppression and unique clinical signs such as a whole body rash and Koplik's spots [1] . In rare cases, humans infected with MV develop fatal neurological complications during or after infection. During the measles rash phase, MV infects neurons through an unknown mechanism and causes neurological inflammation known as primary measles encephalitis [2, 3] . Without infecting the neurons, MV can induce immune-mediated brain inflammation that causes encephalitis, referred to as acute post-measles encephalitis [3, 4] . Measles inclusion-body encephalitis most commonly occurs in immunodeficient children 1-6 months post-infection. They develop a fatal neurological disease with symptoms including seizures, as well as motor and sensory deficits [3] . Several years after MV infection, children, especially those infected while less than 1 year old, develop subacute sclerosing panencephalitis (SSPE), which causes progressive dementia, seizures and ataxia, with high rates of patient mortality within 3 years of symptom onset [3, 5] . Since MV strains isolated from SSPE patients often contain mutations in their genomes, there might be several mutations required for the development of SSPE [6] . To date, the mechanism of neuropathogenesis and persistent infection of MV remains unclear, and no effective treatment for fatal MV-induced encephalitis is available.
To establish an animal model of MV-induced encephalitis, several rodent brain-adapted strains of MV have been generated [7] [8] [9] [10] . A rodent brain-adapted MV strain CAMR40 was generated by passaging the MV vaccine strain CAM-70 40 times in rat brain, and strain CAM/RB was further adapted by passaging strain CAMR40 four times in rat brain [10, 11] . It has been reported that MV strain CAM/RB causes fatal acute encephalitis in suckling rats. In the case of aged rats, CAM/RB causes subacute encephalitis with a low mortality rate in Lewis rats, while clinically silent encephalitis in Brown Norway rats.
These differences in clinical symptoms between the two rat strains are considered to be related to the immunogenic background [11] . It has also been reported that CAM/RB infects brain tissue exclusively, and the synthesis of envelope proteins, including matrix, fusion and haemagglutinin (H) proteins, is restricted in the infected neurons [11, 12] , which has been similarly described in the brains of SSPE patients [13, 14] . During the immune response to CAM/RB infection, it has been reported that CD4 + T cells, but not CD8 + T cells, are essential for the production of antiviral antibodies and viral clearance [15] , and the activation of T helper type 1 cells by interferon (IFN) gamma plays a critical role in viral clearance [16] . Adaptive mutations in strain CAM/RB conferring neurovirulence in MV have been investigated by generating recombinant MV strains. Substitution of the H gene of the MV vaccine strain Edmonston (Ed) with that of strain CAM/RB conferred neurovirulence on the resulting Ed strain (Edtag-CAMH), suggesting that the H gene of CAM/RB is responsible for viral entry into mouse neuronal cells [17] . However, in the same study, it was reported that the progression of Edtag-CAMH in the mouse brain was reduced compared with that of the parental strain CAM/RB, suggesting that unknown adaptive changes other than those in the H gene are required for the full neurovirulence of CAM/RB. We previously reported that the H gene is the determinant of tropism and the phosphoprotein (P) gene is the determinant of pathogenicity in vivo in canine distemper virus and rinderpest virus, which belong to the genus Morbillivirus along with MV [18] [19] [20] . Therefore, in the present study, we generated recombinant chimeric MVs based on wild-type strain HL [21] in which the H and/or P genes were replaced with those of CAMR40, and the pathogenicity of these recombinant MVs (rMVs) was examined in mouse brain.
RESULTS

Generation and growth characterization of rMVs
To evaluate the roles of the P and H genes of CAMR40, we generated rMVs in which these genes were replaced with those of CAMR40 (Fig. 1a) . It has been reported that the H gene of strain CAM/RB conferred neurovirulence on strain Ed [17] , thus recombinant MV possessing the Ed P gene was also generated. The growth kinetics of these viruses were measured using B95a or Vero cells. In B95a cells, all of the parental and recombinant viruses showed similar growth curves (Fig. 1b) . By contrast, in Vero cells, the growth rate of strain CAMR40 was considerably higher and decreased 72 h post-infection (h p.i.) owing to its cytotoxicity (Fig. 1c) . The recombinant MVs possessing the CAMR40 H gene (HL-CAMH, HL-CAMPH and HL-EdP-CAMH) showed similar growth rates until 96 h p.i. At 96 h p.i., the titres of HL-CAMPH and HL-CAMH continued to increase up until 168 h p.i., but that of HL-EdP-CAMH decreased. The peak titres of strains HL and HL-CAMP, which possess the HL H gene, were 10 À2.5 to 10 À3 lower than those of strain CAMR40 and 10 À1.5 to 10 À2 lower than other recombinant MVs in Vero cells, which is probably because Vero cells express no principal receptor for wildtype MV [22, 23] . These results indicated that all of the rMVs grew well in B95a cells, but the H gene of strain CAMR40 is required for efficient infection of Vero cells.
Neurovirulence of rMVs
Next, to evaluate neurovirulence, 7-day-old neonatal mice were intracerebrally inoculated with 1.4Â10 4 of the median tissue culture infectious dose (TCID 50 ) of MV. As expected, the mice inoculated with the HL strain developed no signs of disease (Fig. 2b) . Those infected with the CAMR40 strain developed fatal neurological symptoms, including seizure, coma, tremors and lethargy (Fig. 2b) . Mortality was first observed at 3 days post-infection (days p.i.), resulting in a final rate of 100 % (Fig. 2a) , similar to that previously reported [10] . As seen in the parental HL strain, HL-CAMP caused no signs of disease in the mice (Fig. 2b) , suggesting that the infection had not been established owing to the absence of the CAMR40 H gene. HL-CAMH caused several signs in three mice, but they were much milder than those caused by strain CAMR40 (Fig. 2b ) and there were no resultant fatalities (Fig. 2a) . HL-EdP-CAMH, which possessed the P gene of strain Ed, caused neurological signs that were marginally more severe than those of HL-CAMH (Fig. 2b ), but all of the mice survived (Fig. 2a) . By contrast, HL-CAMPH, which possessed the CAMR40 P and H genes, caused severe neurological signs similar to those of strain CAMR40 (Fig. 2b) , with fatalities commencing at 5 days p.i. and leading to 100 % mortality (Fig. 2a) . The changes in body weight of the infected mice are shown in Fig. 3 . The body weights of the mock-infected mice, as well as those of the mice inoculated with MV HL or HL-CAMP, increased with time. However, the body weights of eight of the 12 mice inoculated with HL-CAMH remained unchanged or decreased slightly, while HL-EdP-CAMH caused transient body weight loss in three of the 16 mice at 5-6 days p.i. By contrast, CAMR40 and HL-CAMPH caused severe body weight loss followed by death. Therefore, HL-CAMPH was much more virulent in mouse brains than either HL-CAMH or HL-EdP-CAMH, and its pathogenicity was almost comparable to that of the parental MV CAMR40. These results clearly indicated that the H gene of CAMR40 is necessary for the establishment of infection and the P gene is critical for the expression of neurovirulence.
Growth and propagation of rMVs in the mouse brain
To compare the growth of mildly neurovirulent strain HL-CAMH and severely neurovirulent strains HL-CAMPH and CAMR40, the viral titres in the brain homogenates were quantitated. Although large amounts of infectious viruses were detected in the brains infected with CAMR40 and HL-CAMPH, the viral titre in brain infected with HL-CAMH was below the detection limit (Fig. 4a) . To evaluate viral growth in the mouse brain in detail, we performed a quantitative PCR assay. No mRNA of the N gene was detected in brain infected with MV strain HL, and small amounts of N mRNA were detected in only half of the mice infected with mildly neurovirulent HL-CAMH (Fig. 4b) . By contrast, high and comparable N gene expression was quantitated in the brains infected with CAMR40 and HL-CAMPH (Fig. 4b) . These results indicated that the P gene of CAMR40 is required for efficient replication of MV in the mouse brain. To investigate viral propagation, coronal sections of the brains infected with HL-CAMH, HL-CAMPH and CAMR40 were analysed by immunohistochemistry assay. In the brains infected with HL-CAMPH and CAMR40, a large amount of viral antigens were detected in the left cerebral cortex, where the viruses were inoculated, whereas little antigen was detected in the brain infected with HL-CAMH (Fig. 5a-c) . To evaluate the immune responses, we performed haematoxylin-eosin (HE) staining of serial sections. HE staining indicated comparable infiltration of immune cells from the blood vessels in both brains infected with CAMR40 and HL-CAMPH (Fig. 5d, e) , as previously reported in mouse brains infected with MV [24] . We also performed Klüver-Barrera staining to evaluate the brain lesions and observed severe necrosis of the neurons at the Ammon's horn of the hippocampus in the brain infected with CAMR40 ( Fig. 5f ), but not in the brain infected with HL-CAMPH. As previously reported [24] , white matter vacuolization was also observed in the focal area of both brains infected with CAMR40 and HL-CAMPH (Fig. 5g, h ).
It has been reported that neural apoptosis is induced in the brains of SSPE patients and mouse brains infected with MV [25, 26] . To investigate further, we performed a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay and observed neuronal apoptosis in mouse brains infected with CAMR40 and HL-CAMPH but not HL-CAMH (Fig. 6 ). These results indicated that the P gene of CAMR40 is a key determinant of neurovirulence in vivo.
DISCUSSION
In this study, we successfully generated chimeric rMVs using reverse genetics and attempted to identify the genes responsible for CAMR40 pathogenicity. We first evaluated the viral growth rates of the rMVs in B95a cells and Vero cells. HL-CAMH and HL-CAMPH grew similarly to CAMR40 in B95a cells, and expressed one of the MV receptors, signalling lymphocytic activation molecule (SLAM) [23] . In Vero cells, the titre of CAMR40 reached a maximum earlier than for HL-CAMH and HL-CAMPH and then decreased rapidly (Fig. 1c) . The Vero cells expressed no principal receptors for wild-type MV, whereas CAMR40 and its ancestor strain CAM-70 displayed large syncytium formation. Therefore, we speculate that the genome of CAMR40 harbours uncharacterized mutations in genes other than P and H, which are responsible for rapid virus growth and the consequent cytotoxicity in Vero cells.
We next evaluated the pathogenicity of rMVs in mouse brains. Although all of the mice infected with HL-CAMPH died (similar to CAMR40 infection), the onset of symptoms with HL-CAMPH (5 days p.i.) was slightly later than that with CAMR40 (3 days p.i.) (Fig. 2a) . Furthermore, CAMR40 caused severe lesions and necrosis of neurons in mouse brains (Fig. 5f ). Therefore, we speculate that CAMR40 grows faster than HL-CAMPH in vivo, as seen in Vero cells (Fig. 1c) , and causes severe necrosis of neurons, resulting in early mortality.
Previously, Duprex et al. generated a recombinant MV Ed strain harbouring the H gene of CAM-RB (Edtag CAMH) and reported that the growth of EdtagCAMH in mouse brain was decreased compared with CAM-RB [17] . Our results indicated that the neurovirulence of HL-CAMH and HL-EdP-CAMH was weak and non-lethal relative to HL-CAMPH. These results supported the conclusion that the P gene of CAMR40 confers neurovirulence. We previously reported that recombination of the P gene, in addition to the H gene, is required for the pathogenicity of lapinized rinderpest virus and rodent brain-adapted canine distemper virus [19, 20] . These results strongly suggested that adaptation of the P gene is commonly required for cross-species pathogenesis of morbilliviruses.
Our results clearly indicated that the P gene of CAMR40 is a key determinant for neurovirulence, but the specific amino acid mutations in the P gene products responsible for this phenotype remain unknown. On comparing the amino acid sequences of the P, V and C proteins in the HL and CAMR40 strains, there was around a 4.9 % difference (25/507) between the P proteins, around 5.9 % difference (4/ 68) in the V protein-specific region, and around 3.8 % difference in the C protein (7/186). We further analysed these mutations among strain CAMR40 and five SSPE strains: ZH, CapeTown.ZAF/52.14[B3], Kitaken-1, Kobe-1 and Toulon.FRA/08.07 (GenBank accession numbers: AB453187, KT851534, AB453045, AB254456 and HM562909). Within the common regions of the P and V proteins, two amino acid residues, H111 and N217, in the wild-type strain were mutated in the SSPE strains with high . Body weight change in infected mice. Mice were inoculated as described for Fig. 2 and their body weights measured daily.
probability (3/5 and 4/5, respectively). In addition, P25 and T39 in the wild-type C protein were mutated with high probability (3/5 and 4/5, respectively). These mutations in the P and C proteins may contribute to the adaptation of MV to neurons. P protein is known as a co-factor of the viral RNA-dependent RNA polymerase [27, 28] , but all of the rescued rMVs grew well in B95a and Vero cells, indicating that the regulatory function of the P protein in viral replication in vitro is not affected by the adaptive mutations. Therefore, we speculate that alterations in the interaction between P gene products and host proteins are responsible for the adaptation to neurons. It has been reported that P and V proteins interact with host signal transducer and activator of transcription (STAT) proteins to suppress IFN response signalling [29, 30] . V protein also interacts with melanoma differentiation associated gene 5 (MDA5) to suppress IFN production [31] . C protein also inhibits IFN response signalling [32] . Patterson et al. reported that the V and C proteins function as virulence factors in mouse brain [33] , so the antagonistic activities of the V and C proteins in the IFN system might contribute to neuropathogenesis.
In this study, we have established a useful system for the evaluation of MV neuropathogenicity and revealed that the P gene is a key determinant of neurovirulence in MV. Future functional analyses of the CAMR40 P gene products will provide valuable information for understanding the molecular mechanisms underlying the neurological diseases caused by MV.
METHODS
Cells and viruses
B95a cells (Epstein-Barr virus-transformed marmoset Blymphoblastoid cells) [34] were maintained in RPMI 1640 medium supplemented with 5 % foetal calf serum (FCS).
Vero cells (African green monkey kidney cells) and HEK293 cells (human embryonic kidney cells) were maintained under 5 % CO 2 at 37 C in Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 5 % FCS. Recombinant vaccinia virus (MVAGKT7) expressing the bacteriophage T7 RNA polymerase was provided by G. Sutter (National Research Centre for Environment and Health, Oberschleissheim, Germany). For the propagation of MVs, Vero cells were infected with MV strain CAMR40 or HL-EdP-CAMH, and B95a cells were infected with the other rMVs. The viruses were harvested by freeze-thaw and sonication when syncytium formation was at a maximum. For titration, the viruses were serially diluted, incubated with B95a cells and the TCID 50 calculated.
Construction of plasmids
To obtain viral cDNA, Vero cells were infected with MV strain CAMR40 and total RNA was extracted using ISOGEN (Nippongene) according to the manufacturer's instructions. The cDNA was synthesized by reverse transcription of the RNA using Superscript II (Invitrogen) and was then used as a PCR template. A flow chart describing the construction of plasmids containing the complete genomes of the chimeric recombinants MVs (full-genome plasmids) is provided in Fig.  S1 (available with the online Supplementary Material). We previously constructed cloning plasmids containing either the N/P intergenic region (N/P IGR) between the N and P genes and the P gene open reading frame of the MV HL strain (pSK HL-P) or the F/H IGR between the F and G genes and the H gene open reading frame of the MV HL strain (pSK HL-H) [21] . For the cloning of CAMR40 genes, PCR-amplified cDNA of the CAMR40 P gene was inserted between the NsiI and PmeI sites of pSK HL-P, and that of the CAMR40 H gene was inserted between the EcoRV and AscI sites of pSK HL-H. To generate full-genome plasmids of rMV-HL-CAMP, HL- CAMH and HL-CAMPH, cDNA fragments of the CAM-P and/or CAM-H genes were excised from pSK CAM-P and/or pSK CAM-H with specific restriction enzymes (P gene: FseI and PmeI; H gene: SgfI and AscI), and were inserted into the corresponding sites of pMV-HL(7+), which is the original full-genome plasmid of strain MV-HL [21] . To generate the full-genome plasmid HL-EdP-CAMH, the cDNA of the P gene of MV Ed strain was excised with FseI and PmeI from the pMV-Ed plasmid that was previously generated [35] and inserted into the full-genome plasmid of HL-CAMH.
Rescue of rMVs from cDNA
The rescue of recombinant viruses was performed as described in a previous report [21] . In brief, HEK293 cells were infected with replication-deficient vaccinia virus MVAGKT7 and incubated for 1 h. The cells were transfected with the full-genome plasmids together with the supporting plasmids pKS-N, pKS-P and pGEM L, which express the N, P and L proteins, respectively, and were incubated in DMEM supplemented with 2 % FCS. At 4 days p.i., B95a cells were laid over the HEK293 cells to propagate the virus and were incubated in RPMI 1640 medium supplemented with 2 % FCS. After large syncytia formed, the virus was collected and propagated as described above.
Analysis of viral growth kinetics
B95a and Vero cells infected with viruses at a multiplicity of infection (m.o.i.) of 0.01, were incubated in RPMI 1640 medium and DMEM, respectively, and both were supplemented with 2 % FCS. At different times post-infection, the viruses were collected by three freeze-thaw cycles and sonication. The viral titres were calculated as described above.
To quantitate the viral load in the infected mouse brains (described below), the brains were removed and homogenized with a glass homogenizer in DMEM supplemented with 2 % FCS. After centrifugation, the titres of the supernatants were calculated as described above. Viral titres in brain homogenates of below 3.5 log TCID 50 were undetectable owing to the cytotoxicity of brain homogenates against the cells used for viral detection. . Apoptosis in the brains infected with MV. Neonatal mice were inoculated and brain sections were prepared as described in Fig. 4 . The coronal sections were subjected to an immunohistochemistry assay using anti-MV N-specific antibody (MV N), and apoptosis in the serial sections was detected by a TUNEL assay.
Quantitative PCR assay Total RNA in the brain homogenates was isolated with ISO-GEN (Nippongene). cDNA was synthesized with PrimeScript Reverse Transcriptase (Takara) and a random hexamer primer. Quantitative PCR was performed using the THUNDERBIRD SYBR qPCR Mix (Toyobo) and specific primers for MV N (forward: 5¢-GGAGATTCC TCAATTACCAC-3¢; reverse: 5¢-AGATTGTGACTGGTCA CTCT-3¢) and GAPDH (forward: 5¢-TGCACCACCAAC TGCTTAGC-3¢; reverse: 5¢-TGGATGCAGGGATGATG TTC-3¢).
Animal infection and immunohistochemical staining
All animal experiments were approved by the Animal Experiment Committee at the University of Tokyo and were performed in accordance with the Regulations for Animal Care and Use of the University of Tokyo. C57BL/6j mice were obtained from CLEA Japan and neonatal mice were obtained by breeding. The mice were each inoculated with 25 µl of virus into the left cerebral hemisphere. The body weights and clinical signs of the infected mice were recorded daily. When clinical signs were at their most severe, the brains were excised and fixed in 0.2 M phosphate buffer (pH 7.4) containing 4 % paraformaldehyde for at least 2 days before embedding in paraffin. The brains were sectioned at 6 µm thickness using a microtome. After dewaxing and inactivation of endogenous peroxidase with hydrogen peroxide, the sections were incubated with anti-MV N rabbit serum. After three washes with PBS, the sections were incubated with horseradish peroxidase-conjugated polyclonal goat anti-rabbit immunoglobulins (Dako). After a further three washes with PBS, the sections were stained with 3,3¢-diaminobenzidine tetrahydrochloride and counterstained with haematoxylin. The serial sections were stained by HE staining, and with Luxol fast blue and cresyl violet for Klüver-Barrera staining. Neural apoptosis was detected using the MEBSTAIN Apoptosis TUNEL Kit Direct (MBL) according to the manufacturer's instructions. The pathological specimens were analysed using a BX50 system microscope (Olympus) and an IX70 laser confocal microscope (Olympus).
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